Veterinary medicines

EMA is responsible for the scientific evaluation, supervision and safety monitoring of veterinary medicines in the EU. In 2022, EMA recommended ten medicines for marketing authorisation. Of these, three had a new active substance. Two were vaccines, including one new biotechnological vaccine. This demonstrates the animal health industry’s continued strong interest in developing vaccines. Here are some key figures on the authorisation and safety monitoring of veterinary medicines in 2022. For more detailed information, download the full annual report 2022 (PDF version).